Journal
DRUG METABOLISM AND DISPOSITION
Volume 31, Issue 6, Pages 701-704Publisher
AMER SOC PHARMACOLOGY EXPERIMENTAL THERAPEUTICS
DOI: 10.1124/dmd.31.6.701
Keywords
-
Categories
Funding
- NCRR NIH HHS [RR12023] Funding Source: Medline
- NIA NIH HHS [AG10485] Funding Source: Medline
- NINDS NIH HHS [NS44765] Funding Source: Medline
Ask authors/readers for more resources
According to a recently reported metabolic pathway, phenolic A-ring estrogens are metabolized in rat liver microsomes partially to the corresponding quinols by cytochrome P450 isoenzymes. We found that these quinols could, in turn, undergo reduction to regenerate the parent estrogens consumed during the metabolic process. Among the tested endogenous reducing agents, NADH and especially NADPH produced a significant extent of reductive conversion. Enzymes available in rat liver microsomes further catalyzed this reaction with 6.5 +/- 1.5 nmol min(-1) . (mg of protein)(-1) measured as the initial rate of estrone formation at 37degreesC, whereas the initial rate of second-order reaction for the reduction of E1-quinol by a 10-fold excess of NADPH in a microsome-free buffer solution and under identical incubation conditions was 0.62 +/- 0.03 nmol . min(-1). The quinol route is, therefore, unique among estrogen-metabolizing pathways for its bioreversibility due to the facile regeneration of the phenolic A-ring estrogens consumed in the preceding oxidative process.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available